Hayley R C Shanks

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Cerebrospinal Fluid

Positron Emission Tomography

Placebo Controlled

Top Venues

Nature medicine

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Brain communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine 30 (6) (2024)
Hayley R C Shanks, Kewei Chen, Eric M Reiman, Kaj Blennow, Jeffrey L Cummings, Stephen M Massa, Frank M Longo, Anne Börjesson-Hanson, Manfred Windisch, Taylor W Schmitz
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature medicine (2024)
Hayley R C Shanks, Kate M Onuska, Dinesh K Barupal, Taylor W Schmitz, null null, null null
Serum unsaturated phosphatidylcholines predict longitudinal basal forebrain degeneration in Alzheimer's disease. Brain communications 4 (6) (2022)
Jennifer I Lissemore, Hayley R C Shanks, Meryl A Butters, Apoorva Bhandari, Reza Zomorrodi, Tarek K Rajji, Jordan F Karp, Charles F Reynolds, Eric J Lenze, Zafiris J Daskalakis, Benoit H Mulsant, Daniel M Blumberger
An inverse relationship between cortical plasticity and cognitive inhibition in late-life depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 44 (9) (2019)